Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunoprecipitation01:20

Immunoprecipitation

8.1K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
8.1K
Precipitation and Co-precipitation01:17

Precipitation and Co-precipitation

5.8K
Precipitation and coprecipitation methods can be used to separate a mixture of ions in a solution. In qualitative inorganic analysis, ions that form sparingly soluble precipitates with the same reagent are separated based on the differences in solubility products. For example, consider the separation of Cu(II) and Fe(II) ions by precipitation as insoluble sulfides. First, copper(II) sulfide is precipitated by the addition of acidic H2S, where the dissociation of H2S is suppressed. Adding H2S...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply: Reconsidering fibrinolytic assessment and hemostatic management in liver transplantation.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Regeneration of new periodontal attachment following surgical removal of a Peripheral Giant Cell Granuloma in a young patient: an 8-year follow-up.

European journal of paediatric dentistry·2025
Same author

Use of viscoelastic tests in the principle bleeding scenarios in Spanish hospitals.

Revista espanola de anestesiologia y reanimacion·2023
Same author

Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study.

Revista espanola de anestesiologia y reanimacion·2023
Same author

[Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study].

Revista espanola de anestesiologia y reanimacion·2022
Same author

Clinical characterization of gingival type of burning mouth syndrome: a cross-sectional study.

Medicina oral, patologia oral y cirugia bucal·2021

Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.4K

[The cryoprecipitate: that old unknown].

A Blasi1, J Beltran1, A Pereira2

  • 1Servicio de Anestesiología y Reanimación, Hospital Clínic. IDIBAPS, Barcelona, España.

Revista Espanola De Anestesiologia Y Reanimacion
|January 7, 2015
PubMed
Summary
This summary is machine-generated.

Cryoprecipitate, a plasma product rich in fibrinogen, is vital for treating bleeding disorders. Despite its established use, a decline in its production and understanding necessitates a review of its characteristics and indications.

Keywords:
CrioprecipitadoCryoprecipitateFibrinogenFibrinógenoTransfusionTransfusión

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.6K
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

13.8K

Related Experiment Videos

Last Updated: Apr 19, 2026

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.4K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.6K
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

13.8K

Area of Science:

  • Transfusion Medicine
  • Hematology
  • Anesthesiology

Background:

  • Cryoprecipitate is a plasma derivative containing fibrinogen and other crucial clotting factors.
  • It has a long history of successful use in managing coagulopathies associated with trauma, surgery, liver failure, and disseminated intravascular coagulation.
  • Production of cryoprecipitate has decreased in some regions, and there is a trend towards using fibrinogen concentrate instead.

Purpose of the Study:

  • To describe the characteristics of cryoprecipitate.
  • To differentiate cryoprecipitate from manufactured fibrinogen concentrate.
  • To highlight the specific indications for cryoprecipitate that warrant further clinical investigation.

Main Methods:

  • Literature review on cryoprecipitate composition and historical use.
  • Comparative analysis of cryoprecipitate and fibrinogen concentrate.
  • Discussion of clinical scenarios where cryoprecipitate is indicated.

Main Results:

  • Cryoprecipitate is a complex biological product with a unique profile of procoagulant factors.
  • Its efficacy in specific coagulopathies is well-documented but may be underutilized due to production changes.
  • Distinct indications exist for cryoprecipitate that differ from fibrinogen concentrate.

Conclusions:

  • Cryoprecipitate remains a valuable therapeutic agent for specific bleeding conditions.
  • Further clinical trials are needed to fully elucidate and confirm the indications for cryoprecipitate.
  • Education on cryoprecipitate's properties is essential for current medical practitioners, especially anesthesiologists.